Decrease in tobacco consumption after treatment with topiramate and aripiprazole: A case report

5Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: A large part of research into drug addiction focuses on mesolimbic dopamine circuitry; however, both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and/or kainate and dopamine D2 receptors can play a role in maintaining the established addiction. Case presentation: We report the case of a 34-year-old man who compulsively smoked 80 to 100 cigarettes each day. After receiving treatment with topiramate and aripiprazole, his tobacco consumption was dramatically reduced. Conclusion: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and/ or kainate blocking agents and a dopamine D2 receptor partial agonist may be novel instruments for nicotine abuse disorders. © 2008 Arbaizar et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Arbaizar, B., Gómez-Acebo, I., & Llorca, J. (2008). Decrease in tobacco consumption after treatment with topiramate and aripiprazole: A case report. Journal of Medical Case Reports, 2. https://doi.org/10.1186/1752-1947-2-198

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free